Migraine as a Risk Factor for Subclinical Brain Lesions

JAMA

Volumn 291, Issue 4, 2004, Pages 427-434

  Kruit, Mark C ^a   Van Buchem, Mark A ^a   Hofman, Paul A M ^b   Bakkers, Jacobus T N ^c   Terwindt, Gisela M ^a   Ferrari, Michel D ^a   Launer, Lenore J ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SLINGELAND HOSPITAL   (Netherlands)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT;

ADULT; AGE; ANAMNESIS; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; BRAIN INFARCTION; BRAIN INJURY; CARDIOVASCULAR RISK; CEREBELLUM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STROKE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

EID: 1542365240     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.4.427     Document Type: Article

References (47)

1. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8(suppl 7):1-96.
2. Ferrari MD. Migraine. Lancet. 1998;351:1043-1051.
3. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ. 1995;310:830-833.
4. Carolei A, Marini C, De Matteis G, The Italian National Research Council Study Group on Stroke in the Young. History of migraine and risk of cerebral ischaemia in young adults. Lancet. 1996;347:1503-1506.
5. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study: the World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 1999;318:13-18.
6. Merikangas KR, Fenton BT, Cheng SH, et al. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol. 1997;54:362-368.
7. Buring JE, Hebert P, Romero J, et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol. 1995;52:129-134.
8. Milhaud D, Bogousslavsky J, Van Melle G, et al. Ischemic stroke and active migraine. Neurology. 2001;57:1805-1811.
9. Hoekstra-van Dalen RA, Cillessen JP, Kappelle LJ, et al. Cerebral infarcts associated with migraine: clinical features, risk factors and follow-up. J Neurol. 1996;243:511-515.
10. Fazekas F, Koch M, Schmidt R, et al. The prevalence of cerebral damage varies with migraine type: a MRI study. Headache. 1992;32:287-291.
11. Pavese N, Canapicchi R, Nuti A, et al. White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia. 1994;14:342-345.
12. De Benedittis G, Lorenzetti A, Sina C, et al. Magnetic resonance imaging in migraine and tension-type headache. Headache 1995;35:264-268.
13. Sacco RL. Risk factors, outcomes, and stroke subtypes for ischemic stroke. Neurology. 1997;49:S39-S44.
14. Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke. 1996;27:1274-1282.
15. Bernick C, Kuller L, Dulberg C, et al. Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology. 2001;57:1222-1229
16. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
17. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53:537-542.
18. Price TR, Psaty B, O'Leary D, et al. Assessment of cerebrovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1993;3:504-507.
19. Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol. 1998;245:116-122.
20. Tatu L, Moulin T, Bogousslavsky J, et al. Arterial territories of human brain: brainstem and cerebellum. Neurology. 1996;47:1125-1135.
21. Tatu L, Moulin T, Bogousslavsky J, et al. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998;50:1699-1708.
22. Scheltens P, Barkhof F, Leys D, et al. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci. 1993;114:7-12.
23. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70:9-14.
24. Boer JM, Feskens EJ, Schouten EG, et al. Lipid profiles reflecting high and low risk for coronary heart disease: contribution of apolipoprotein E polymorphism and lifestyle. Atherosclerosis. 1998;136:395-402.
25. Alexander JA, Sheppard S, Davis PC, et al. Adult cerebrovascular disease: role of modified rapid fluid-attenuated inversion-recovery sequences. AJNR Am J Neuroradiol. 1996;17:1507-1513.
26. Donaghy M, Chang CL, Poulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry, 2002;73:747-750.
27. Ducros A, Denier C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345:17-24.
28. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543-552.
29. Caplan LR. Migraine and posterior circulation stroke. In: Caplan LR. Posterior Circulation Disease: Clinical Findings, Diagnosis and Management. Cambridge, Mass: Blackwell Science; 1996:555-556.
30. Bogousslavsky J, Regli F, Maeder P, et al. The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography. Neurology. 1993;43:1528-1533.
31. Pessin MS, Lathi ES, Cohen MB, et al. Clinical features and mechanism of occipital infarction. Ann Neurol. 1987;21:290-299.
32. Caplan LR. Migraine and vertebrobasilar ischemia. Neurology. 1991;41:55-61.
33. Bednarczyk EM, Remler B, Weikart C, et al. Global cerebral blood flow, blood volume, and oxygen metabolism in patients with migraine headache. Neurology. 1998;50:1736-1740.
34. Sanchez del Rio M, Bakker D, Wu O, et al. Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia. 1999;19:701-707.
35. Crassard I, Conard J, Bousser MG. Migraine and haemostasis. Cephalalgia. 2001;21:630-636.
36. Tietjen GE, Al Qasmi MM, Athanas K, et al. Increased von Willebrand factor in migraine. Neurology. 2001;57:334-336.
37. Tzourio C, El Amrani M, Poirier O, et al. Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism. Neurology. 2001;56:1273-1277.
38. Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain. 2002;125:102-112.
39. Goadsby PJ, Silberstein, SD, eds. Pathophysiology of migraine: a disease of the brain. In: Goadsby PJ, et al. Headache. Boston, Mass: Butterworth-Heinemann; 1997:5-25.
40. Eggers AE. New neural theory of migraine. Med Hypotheses. 2001;56:360-363.
41. Spence JD, Wong DG, Melendez LJ, et al. Increased prevalence of mitral valve prolapse in patients with migraine. CMAJ. 1984;131:1457-1460.
42. Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology, 1999;52:1622-1625.
43. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Colch). 2001;100:215-220.
44. Goldberg MP, Ransom BR. New light on white matter. Stroke. 2003;34:330-332.
45. Wender R, Brown AM, Fern R, et al. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci. 2000;20:6804-6810.
46. Gallo V, Ghiani CA. Glutamate receptors in glia: new cells, new inputs and new functions. Trends Pharmacol Sci. 2000;21:252-258.
47. Fujita S, Kawaguchi T. Association of platelet hyper-aggregability with leukoaraiosis. Acta Neurol Scand. 2002;105:445-449.